Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Models, Genetic | 31 | 2023 | 926 | 5.030 |
Why?
|
Polymorphism, Single Nucleotide | 37 | 2024 | 2357 | 3.460 |
Why?
|
Genome-Wide Association Study | 23 | 2024 | 1621 | 3.130 |
Why?
|
Bayes Theorem | 22 | 2023 | 361 | 2.770 |
Why?
|
Genetics, Population | 17 | 2019 | 394 | 2.760 |
Why?
|
Models, Statistical | 10 | 2020 | 574 | 1.880 |
Why?
|
Single-Cell Analysis | 4 | 2023 | 134 | 1.760 |
Why?
|
Software | 12 | 2019 | 654 | 1.740 |
Why?
|
Algorithms | 18 | 2023 | 1830 | 1.690 |
Why?
|
Genomics | 7 | 2020 | 720 | 1.670 |
Why?
|
Sequence Analysis, RNA | 10 | 2023 | 217 | 1.570 |
Why?
|
Genetic Variation | 20 | 2021 | 1351 | 1.560 |
Why?
|
Gene Expression Regulation | 19 | 2021 | 1920 | 1.550 |
Why?
|
Haplotypes | 13 | 2019 | 642 | 1.450 |
Why?
|
Gene Expression Profiling | 15 | 2023 | 1384 | 1.380 |
Why?
|
Genome | 7 | 2020 | 372 | 1.340 |
Why?
|
Genotype | 20 | 2023 | 1851 | 1.300 |
Why?
|
Quantitative Trait Loci | 19 | 2024 | 576 | 1.290 |
Why?
|
Data Interpretation, Statistical | 4 | 2019 | 297 | 1.270 |
Why?
|
Linkage Disequilibrium | 7 | 2022 | 473 | 1.240 |
Why?
|
Elephants | 4 | 2015 | 16 | 1.230 |
Why?
|
Recombination, Genetic | 11 | 2018 | 439 | 1.150 |
Why?
|
Phenotype | 16 | 2024 | 2378 | 1.090 |
Why?
|
Genome, Human | 13 | 2018 | 756 | 0.960 |
Why?
|
Genetic Techniques | 4 | 2008 | 72 | 0.950 |
Why?
|
Gene Expression | 9 | 2023 | 1284 | 0.860 |
Why?
|
DNA | 5 | 2018 | 1294 | 0.720 |
Why?
|
Computational Biology | 4 | 2020 | 528 | 0.690 |
Why?
|
Workflow | 1 | 2019 | 77 | 0.690 |
Why?
|
Humans | 80 | 2024 | 86643 | 0.670 |
Why?
|
Information Dissemination | 1 | 2019 | 103 | 0.670 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 5 | 2015 | 378 | 0.650 |
Why?
|
Computer Simulation | 11 | 2023 | 1078 | 0.650 |
Why?
|
Transcriptome | 7 | 2024 | 580 | 0.650 |
Why?
|
Multivariate Analysis | 3 | 2019 | 999 | 0.630 |
Why?
|
Sequence Alignment | 1 | 2018 | 351 | 0.630 |
Why?
|
Population | 2 | 2008 | 35 | 0.610 |
Why?
|
DNA Damage | 1 | 2019 | 366 | 0.600 |
Why?
|
Chromosome Mapping | 8 | 2020 | 1074 | 0.570 |
Why?
|
Linear Models | 2 | 2014 | 421 | 0.540 |
Why?
|
Response Elements | 1 | 2015 | 63 | 0.530 |
Why?
|
Microsatellite Repeats | 4 | 2015 | 145 | 0.520 |
Why?
|
Population Dynamics | 2 | 2019 | 130 | 0.520 |
Why?
|
Lipoproteins, LDL | 1 | 2015 | 83 | 0.520 |
Why?
|
Alleles | 7 | 2018 | 1128 | 0.510 |
Why?
|
Principal Component Analysis | 4 | 2010 | 155 | 0.510 |
Why?
|
Amino Acid Substitution | 1 | 2015 | 339 | 0.500 |
Why?
|
Multifactorial Inheritance | 3 | 2024 | 159 | 0.490 |
Why?
|
Cluster Analysis | 3 | 2023 | 369 | 0.480 |
Why?
|
Interleukin-2 | 1 | 2013 | 249 | 0.440 |
Why?
|
RNA | 1 | 2017 | 560 | 0.440 |
Why?
|
Mutation | 6 | 2019 | 3968 | 0.440 |
Why?
|
Arabidopsis | 1 | 2015 | 314 | 0.420 |
Why?
|
Carcinoma | 1 | 2015 | 436 | 0.420 |
Why?
|
Genetic Association Studies | 1 | 2013 | 294 | 0.400 |
Why?
|
Reproducibility of Results | 5 | 2022 | 2705 | 0.400 |
Why?
|
Emigration and Immigration | 3 | 2008 | 48 | 0.390 |
Why?
|
Likelihood Functions | 4 | 2022 | 251 | 0.370 |
Why?
|
Evolution, Molecular | 6 | 2018 | 813 | 0.370 |
Why?
|
Transcription Factors | 5 | 2015 | 1565 | 0.370 |
Why?
|
Crossing Over, Genetic | 2 | 2006 | 33 | 0.370 |
Why?
|
Diploidy | 2 | 2007 | 30 | 0.360 |
Why?
|
Databases, Genetic | 6 | 2012 | 260 | 0.340 |
Why?
|
Gene-Environment Interaction | 3 | 2018 | 103 | 0.340 |
Why?
|
Induced Pluripotent Stem Cells | 3 | 2020 | 104 | 0.340 |
Why?
|
Mathematical Computing | 1 | 2008 | 21 | 0.340 |
Why?
|
Gene Frequency | 3 | 2015 | 677 | 0.330 |
Why?
|
Genetic Markers | 2 | 2007 | 476 | 0.330 |
Why?
|
Primates | 4 | 2018 | 151 | 0.320 |
Why?
|
Genetics, Medical | 1 | 2008 | 52 | 0.320 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 2013 | 567 | 0.320 |
Why?
|
Selection, Genetic | 6 | 2018 | 502 | 0.310 |
Why?
|
Crohn Disease | 1 | 2013 | 730 | 0.300 |
Why?
|
Commerce | 1 | 2007 | 29 | 0.300 |
Why?
|
Gene Conversion | 1 | 2006 | 25 | 0.290 |
Why?
|
Monte Carlo Method | 3 | 2015 | 185 | 0.290 |
Why?
|
Animals | 21 | 2024 | 26582 | 0.290 |
Why?
|
RNA, Messenger | 6 | 2020 | 1981 | 0.280 |
Why?
|
Transcription, Genetic | 5 | 2017 | 1135 | 0.280 |
Why?
|
Artifacts | 1 | 2008 | 244 | 0.280 |
Why?
|
Simvastatin | 4 | 2014 | 106 | 0.270 |
Why?
|
High-Throughput Nucleotide Sequencing | 2 | 2020 | 456 | 0.270 |
Why?
|
Neoplasms | 3 | 2019 | 2898 | 0.260 |
Why?
|
Dentin | 1 | 2004 | 6 | 0.260 |
Why?
|
Polymorphism, Genetic | 5 | 2012 | 819 | 0.250 |
Why?
|
Regression Analysis | 2 | 2018 | 596 | 0.250 |
Why?
|
Amidinotransferases | 2 | 2014 | 5 | 0.250 |
Why?
|
Africa | 4 | 2010 | 98 | 0.250 |
Why?
|
Geography | 5 | 2008 | 223 | 0.240 |
Why?
|
Cell Line | 10 | 2021 | 2468 | 0.240 |
Why?
|
Muscular Diseases | 2 | 2014 | 63 | 0.240 |
Why?
|
Genetic Predisposition to Disease | 4 | 2024 | 2271 | 0.230 |
Why?
|
Models, Biological | 4 | 2019 | 1749 | 0.230 |
Why?
|
Biological Evolution | 3 | 2019 | 919 | 0.210 |
Why?
|
Deoxyribonuclease I | 2 | 2012 | 28 | 0.210 |
Why?
|
Markov Chains | 4 | 2013 | 125 | 0.210 |
Why?
|
Sequence Analysis, DNA | 5 | 2019 | 853 | 0.210 |
Why?
|
Genetic Linkage | 1 | 2003 | 623 | 0.200 |
Why?
|
Models, Theoretical | 2 | 2015 | 482 | 0.200 |
Why?
|
Glucocorticoids | 3 | 2013 | 352 | 0.200 |
Why?
|
Poisson Distribution | 1 | 2021 | 51 | 0.200 |
Why?
|
Genetic Pleiotropy | 1 | 2020 | 24 | 0.190 |
Why?
|
Mendelian Randomization Analysis | 1 | 2020 | 43 | 0.180 |
Why?
|
Sepsis | 1 | 2024 | 306 | 0.180 |
Why?
|
Cytokines | 1 | 2024 | 776 | 0.180 |
Why?
|
Terminology as Topic | 1 | 2021 | 217 | 0.180 |
Why?
|
Tropical Climate | 1 | 2019 | 31 | 0.180 |
Why?
|
Promoter Regions, Genetic | 3 | 2020 | 937 | 0.170 |
Why?
|
Oncogenes | 1 | 2019 | 88 | 0.170 |
Why?
|
Animal Distribution | 1 | 2019 | 21 | 0.170 |
Why?
|
DNA, Ancient | 1 | 2019 | 18 | 0.170 |
Why?
|
Polyploidy | 1 | 2018 | 17 | 0.170 |
Why?
|
DNA Transposable Elements | 2 | 2018 | 169 | 0.170 |
Why?
|
Coffea | 1 | 2018 | 2 | 0.170 |
Why?
|
Molecular Sequence Annotation | 1 | 2018 | 67 | 0.160 |
Why?
|
Europe | 4 | 2019 | 309 | 0.160 |
Why?
|
Myocytes, Cardiac | 1 | 2021 | 275 | 0.160 |
Why?
|
Cytosine | 1 | 2019 | 127 | 0.160 |
Why?
|
Sex Characteristics | 1 | 2020 | 319 | 0.160 |
Why?
|
Genotyping Techniques | 1 | 2018 | 68 | 0.160 |
Why?
|
Cell Cycle | 1 | 2020 | 502 | 0.160 |
Why?
|
Genome, Plant | 1 | 2018 | 85 | 0.160 |
Why?
|
Adenosine | 1 | 2020 | 225 | 0.150 |
Why?
|
Epigenesis, Genetic | 3 | 2020 | 479 | 0.150 |
Why?
|
Birds | 1 | 2019 | 157 | 0.150 |
Why?
|
Myocardial Infarction | 1 | 2021 | 376 | 0.150 |
Why?
|
Gene Silencing | 1 | 2018 | 172 | 0.150 |
Why?
|
Blastocyst | 1 | 2017 | 34 | 0.150 |
Why?
|
Calibration | 2 | 2008 | 99 | 0.150 |
Why?
|
Pan troglodytes | 3 | 2009 | 197 | 0.150 |
Why?
|
Interleukin-6 | 2 | 2024 | 256 | 0.150 |
Why?
|
Environment | 1 | 2018 | 219 | 0.140 |
Why?
|
Open Reading Frames | 1 | 2016 | 117 | 0.140 |
Why?
|
Transients and Migrants | 1 | 2015 | 6 | 0.140 |
Why?
|
Base Sequence | 2 | 2018 | 2330 | 0.140 |
Why?
|
Oxygen | 1 | 2021 | 726 | 0.140 |
Why?
|
Ribosomes | 1 | 2016 | 111 | 0.140 |
Why?
|
Molecular Biology | 1 | 2016 | 89 | 0.140 |
Why?
|
Animal Migration | 1 | 2015 | 27 | 0.140 |
Why?
|
India | 2 | 2019 | 120 | 0.130 |
Why?
|
Hypoxia | 1 | 2021 | 641 | 0.130 |
Why?
|
Exons | 3 | 2012 | 450 | 0.130 |
Why?
|
Gene Flow | 1 | 2015 | 88 | 0.130 |
Why?
|
Genes, Lethal | 1 | 2015 | 53 | 0.130 |
Why?
|
Genes, Recessive | 1 | 2015 | 87 | 0.130 |
Why?
|
Hybridization, Genetic | 1 | 2015 | 104 | 0.130 |
Why?
|
Receptors, Glucocorticoid | 2 | 2013 | 120 | 0.130 |
Why?
|
Epigenomics | 1 | 2015 | 100 | 0.130 |
Why?
|
Papio | 1 | 2015 | 82 | 0.130 |
Why?
|
Amino Acid Sequence | 1 | 2018 | 2062 | 0.130 |
Why?
|
RNA Stability | 2 | 2012 | 86 | 0.130 |
Why?
|
Protein Binding | 2 | 2015 | 1456 | 0.120 |
Why?
|
DNA Mutational Analysis | 1 | 2015 | 526 | 0.120 |
Why?
|
Asthma | 1 | 2022 | 955 | 0.120 |
Why?
|
Protein Biosynthesis | 1 | 2016 | 378 | 0.120 |
Why?
|
Mitogen-Activated Protein Kinase 14 | 1 | 2013 | 6 | 0.120 |
Why?
|
Proto-Oncogene Proteins c-fyn | 1 | 2013 | 24 | 0.120 |
Why?
|
Male | 13 | 2020 | 40965 | 0.120 |
Why?
|
Organ Specificity | 3 | 2020 | 258 | 0.120 |
Why?
|
ATP-Binding Cassette Transporters | 2 | 2004 | 141 | 0.120 |
Why?
|
Interferon-gamma | 2 | 2024 | 444 | 0.110 |
Why?
|
Helicobacter pylori | 2 | 2003 | 35 | 0.110 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2017 | 623 | 0.110 |
Why?
|
Chromosomes, Human, X | 2 | 2020 | 55 | 0.110 |
Why?
|
Population Groups | 1 | 2012 | 41 | 0.110 |
Why?
|
DNA Modification Methylases | 1 | 2012 | 25 | 0.110 |
Why?
|
DNA Footprinting | 1 | 2012 | 18 | 0.110 |
Why?
|
Lipid Metabolism | 1 | 2013 | 196 | 0.110 |
Why?
|
Female | 12 | 2021 | 44532 | 0.110 |
Why?
|
Arthritis, Rheumatoid | 1 | 2013 | 166 | 0.100 |
Why?
|
Species Specificity | 4 | 2018 | 678 | 0.100 |
Why?
|
Conservation of Natural Resources | 2 | 2015 | 79 | 0.100 |
Why?
|
Molecular Epidemiology | 1 | 2011 | 53 | 0.100 |
Why?
|
Cadherins | 1 | 2012 | 151 | 0.100 |
Why?
|
Signal Transduction | 2 | 2013 | 3241 | 0.100 |
Why?
|
Population Density | 2 | 2019 | 60 | 0.100 |
Why?
|
Dextroamphetamine | 1 | 2012 | 107 | 0.100 |
Why?
|
Regulatory Sequences, Nucleic Acid | 1 | 2012 | 148 | 0.100 |
Why?
|
Anti-Inflammatory Agents | 1 | 2013 | 339 | 0.090 |
Why?
|
Factor Analysis, Statistical | 1 | 2010 | 111 | 0.090 |
Why?
|
Homozygote | 2 | 2007 | 200 | 0.090 |
Why?
|
NF-kappa B | 1 | 2013 | 444 | 0.090 |
Why?
|
Dexamethasone | 1 | 2011 | 326 | 0.090 |
Why?
|
Disease | 2 | 2020 | 90 | 0.090 |
Why?
|
Mice | 3 | 2024 | 11352 | 0.090 |
Why?
|
Cell Line, Tumor | 1 | 2015 | 2426 | 0.090 |
Why?
|
Nigeria | 3 | 2019 | 152 | 0.090 |
Why?
|
Oligonucleotide Array Sequence Analysis | 3 | 2008 | 689 | 0.090 |
Why?
|
Sequence Deletion | 2 | 2006 | 205 | 0.090 |
Why?
|
Transcription Initiation Site | 3 | 2017 | 45 | 0.080 |
Why?
|
Case-Control Studies | 1 | 2013 | 1805 | 0.080 |
Why?
|
Lipids | 1 | 2010 | 269 | 0.080 |
Why?
|
Alternative Splicing | 1 | 2009 | 201 | 0.080 |
Why?
|
Lymphocytes | 3 | 2016 | 464 | 0.080 |
Why?
|
Chromosomes, Human, Pair 7 | 1 | 2008 | 79 | 0.080 |
Why?
|
Quality Control | 1 | 2008 | 117 | 0.080 |
Why?
|
Hepatocyte Nuclear Factor 1-alpha | 1 | 2008 | 80 | 0.080 |
Why?
|
Forests | 2 | 2019 | 20 | 0.080 |
Why?
|
DNA Methylation | 1 | 2012 | 628 | 0.080 |
Why?
|
Macaca mulatta | 1 | 2009 | 459 | 0.080 |
Why?
|
Immunity, Innate | 1 | 2010 | 409 | 0.080 |
Why?
|
C-Reactive Protein | 1 | 2008 | 190 | 0.080 |
Why?
|
Genes, Neurofibromatosis 1 | 1 | 2006 | 2 | 0.070 |
Why?
|
Crime | 1 | 2007 | 36 | 0.070 |
Why?
|
Brain | 1 | 2017 | 2216 | 0.070 |
Why?
|
B-Lymphocytes | 1 | 2011 | 724 | 0.070 |
Why?
|
Genetics, Behavioral | 1 | 2006 | 22 | 0.070 |
Why?
|
DNA-Binding Proteins | 1 | 2012 | 1208 | 0.070 |
Why?
|
Automation | 1 | 2006 | 106 | 0.070 |
Why?
|
Interferon Type I | 1 | 2006 | 175 | 0.070 |
Why?
|
Parent-Child Relations | 1 | 2006 | 77 | 0.070 |
Why?
|
Odds Ratio | 1 | 2007 | 678 | 0.070 |
Why?
|
Probability | 1 | 2006 | 355 | 0.060 |
Why?
|
Biometry | 1 | 2005 | 66 | 0.060 |
Why?
|
Quantitative Trait, Heritable | 2 | 2020 | 124 | 0.060 |
Why?
|
Kinetics | 1 | 2007 | 1513 | 0.060 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2013 | 1373 | 0.060 |
Why?
|
Genetic Heterogeneity | 1 | 2003 | 62 | 0.060 |
Why?
|
Genetic Drift | 1 | 2003 | 37 | 0.060 |
Why?
|
Chromosomes | 1 | 2003 | 96 | 0.060 |
Why?
|
Helicobacter Infections | 1 | 2003 | 34 | 0.060 |
Why?
|
Sex Factors | 2 | 2020 | 1054 | 0.050 |
Why?
|
Coenzyme A | 1 | 2022 | 15 | 0.050 |
Why?
|
Aged | 3 | 2015 | 18415 | 0.050 |
Why?
|
Amino Acids | 1 | 2022 | 252 | 0.050 |
Why?
|
Sensitivity and Specificity | 1 | 2006 | 1991 | 0.050 |
Why?
|
Leukocytes, Mononuclear | 1 | 2022 | 196 | 0.050 |
Why?
|
Internet | 1 | 2003 | 312 | 0.050 |
Why?
|
Pedigree | 2 | 2015 | 966 | 0.050 |
Why?
|
Terminator Regions, Genetic | 2 | 2012 | 14 | 0.050 |
Why?
|
Cells | 1 | 2020 | 32 | 0.050 |
Why?
|
Middle Aged | 3 | 2015 | 25028 | 0.050 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2024 | 683 | 0.050 |
Why?
|
Causality | 1 | 2020 | 81 | 0.050 |
Why?
|
Genes | 1 | 2021 | 305 | 0.050 |
Why?
|
False Positive Reactions | 1 | 2020 | 216 | 0.050 |
Why?
|
Research Design | 1 | 2003 | 594 | 0.050 |
Why?
|
Cholesterol | 2 | 2013 | 356 | 0.040 |
Why?
|
Introns | 2 | 2012 | 289 | 0.040 |
Why?
|
Asia, Southeastern | 1 | 2019 | 16 | 0.040 |
Why?
|
Genes, Reporter | 1 | 2020 | 268 | 0.040 |
Why?
|
Pravastatin | 2 | 2010 | 17 | 0.040 |
Why?
|
RNA, Long Noncoding | 1 | 2020 | 102 | 0.040 |
Why?
|
Mutation Rate | 1 | 2019 | 48 | 0.040 |
Why?
|
Stress, Physiological | 1 | 2021 | 227 | 0.040 |
Why?
|
Chromatin | 2 | 2012 | 380 | 0.040 |
Why?
|
RNA Splicing | 1 | 2020 | 142 | 0.040 |
Why?
|
Ipomoea batatas | 1 | 2018 | 1 | 0.040 |
Why?
|
China | 1 | 2019 | 228 | 0.040 |
Why?
|
Plant Breeding | 1 | 2018 | 7 | 0.040 |
Why?
|
Drosophila melanogaster | 1 | 2003 | 599 | 0.040 |
Why?
|
Methyltransferases | 1 | 2019 | 182 | 0.040 |
Why?
|
Temperature | 1 | 2019 | 396 | 0.040 |
Why?
|
Carcinogenesis | 1 | 2019 | 195 | 0.040 |
Why?
|
Biodiversity | 1 | 2019 | 197 | 0.040 |
Why?
|
Noise | 1 | 2017 | 27 | 0.040 |
Why?
|
Risk Factors | 2 | 2020 | 5417 | 0.040 |
Why?
|
Central African Republic | 1 | 2015 | 2 | 0.030 |
Why?
|
Democratic Republic of the Congo | 1 | 2015 | 5 | 0.030 |
Why?
|
Africa, Western | 1 | 2015 | 10 | 0.030 |
Why?
|
Genetic Testing | 1 | 2020 | 535 | 0.030 |
Why?
|
Grassland | 1 | 2015 | 6 | 0.030 |
Why?
|
Y Chromosome | 1 | 2015 | 28 | 0.030 |
Why?
|
Uganda | 1 | 2015 | 34 | 0.030 |
Why?
|
Liver | 2 | 2011 | 1230 | 0.030 |
Why?
|
Adult | 4 | 2022 | 25648 | 0.030 |
Why?
|
Fertility | 1 | 2015 | 115 | 0.030 |
Why?
|
DNA, Mitochondrial | 1 | 2015 | 183 | 0.030 |
Why?
|
Phylogeny | 2 | 2011 | 1137 | 0.030 |
Why?
|
Antineoplastic Agents | 1 | 2006 | 2360 | 0.030 |
Why?
|
Sterol Regulatory Element Binding Proteins | 1 | 2013 | 3 | 0.030 |
Why?
|
Pregnanolone | 1 | 2012 | 8 | 0.030 |
Why?
|
Cells, Cultured | 1 | 2018 | 2818 | 0.030 |
Why?
|
Gene Knockdown Techniques | 1 | 2013 | 236 | 0.030 |
Why?
|
Drosophila | 1 | 2017 | 498 | 0.030 |
Why?
|
Human Genome Project | 1 | 2012 | 19 | 0.030 |
Why?
|
DNA (Cytosine-5-)-Methyltransferase 1 | 1 | 2012 | 18 | 0.030 |
Why?
|
Statistical Distributions | 1 | 2012 | 9 | 0.030 |
Why?
|
Fragile X Mental Retardation Protein | 1 | 2012 | 7 | 0.030 |
Why?
|
Placebos | 1 | 2012 | 218 | 0.030 |
Why?
|
HapMap Project | 1 | 2012 | 47 | 0.030 |
Why?
|
Endangered Species | 1 | 2011 | 23 | 0.030 |
Why?
|
DNA (Cytosine-5-)-Methyltransferases | 1 | 2012 | 55 | 0.030 |
Why?
|
Histones | 1 | 2014 | 311 | 0.030 |
Why?
|
NAD(P)H Dehydrogenase (Quinone) | 1 | 2011 | 8 | 0.030 |
Why?
|
Data Mining | 1 | 2011 | 42 | 0.030 |
Why?
|
RNA Interference | 1 | 2012 | 369 | 0.020 |
Why?
|
Italy | 1 | 2011 | 106 | 0.020 |
Why?
|
Cell Line, Transformed | 1 | 2011 | 154 | 0.020 |
Why?
|
National Institutes of Health (U.S.) | 1 | 2011 | 122 | 0.020 |
Why?
|
Child | 1 | 2022 | 6927 | 0.020 |
Why?
|
Genetic Loci | 1 | 2012 | 250 | 0.020 |
Why?
|
Consensus Sequence | 1 | 2010 | 64 | 0.020 |
Why?
|
Toll-Like Receptors | 1 | 2010 | 92 | 0.020 |
Why?
|
RNA Splice Sites | 1 | 2010 | 53 | 0.020 |
Why?
|
Immediate-Early Proteins | 1 | 2011 | 164 | 0.020 |
Why?
|
Heptanoic Acids | 1 | 2010 | 72 | 0.020 |
Why?
|
Monocytes | 1 | 2010 | 214 | 0.020 |
Why?
|
Lipopolysaccharides | 1 | 2010 | 286 | 0.020 |
Why?
|
DNA, Complementary | 1 | 2010 | 393 | 0.020 |
Why?
|
Pyrroles | 1 | 2010 | 184 | 0.020 |
Why?
|
Genetic Complementation Test | 1 | 2008 | 97 | 0.020 |
Why?
|
Sample Size | 1 | 2008 | 130 | 0.020 |
Why?
|
Edar Receptor | 1 | 2007 | 2 | 0.020 |
Why?
|
Double-Blind Method | 1 | 2012 | 1823 | 0.020 |
Why?
|
Antiporters | 1 | 2007 | 18 | 0.020 |
Why?
|
MicroRNAs | 1 | 2012 | 534 | 0.020 |
Why?
|
Chromosomes, Human, Pair 19 | 1 | 2006 | 59 | 0.020 |
Why?
|
Chromosomes, Human, Pair 17 | 1 | 2006 | 110 | 0.020 |
Why?
|
Repetitive Sequences, Nucleic Acid | 1 | 2006 | 135 | 0.020 |
Why?
|
Conserved Sequence | 1 | 2006 | 210 | 0.020 |
Why?
|
Drug Synergism | 1 | 2006 | 303 | 0.020 |
Why?
|
Heterozygote | 1 | 2006 | 365 | 0.020 |
Why?
|
Protein Structure, Tertiary | 1 | 2007 | 736 | 0.020 |
Why?
|
Transcriptional Activation | 1 | 2006 | 280 | 0.020 |
Why?
|
Inflammation | 1 | 2010 | 920 | 0.020 |
Why?
|
Pattern Recognition, Automated | 1 | 2005 | 217 | 0.010 |
Why?
|
Polynesia | 1 | 2003 | 3 | 0.010 |
Why?
|
Social Problems | 1 | 2003 | 10 | 0.010 |
Why?
|
Americas | 1 | 2003 | 19 | 0.010 |
Why?
|
Models, Molecular | 1 | 2007 | 1286 | 0.010 |
Why?
|
Asia | 1 | 2003 | 95 | 0.010 |
Why?
|
Indians, North American | 1 | 2003 | 48 | 0.010 |
Why?
|
Agriculture | 1 | 2003 | 38 | 0.010 |
Why?
|
Genes, Bacterial | 1 | 2003 | 198 | 0.010 |
Why?
|
Language | 1 | 2003 | 151 | 0.010 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2005 | 663 | 0.010 |
Why?
|
Adolescent | 1 | 2012 | 8981 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2004 | 3030 | 0.010 |
Why?
|
United States | 1 | 2011 | 6672 | 0.010 |
Why?
|
Bacterial Proteins | 1 | 2003 | 864 | 0.010 |
Why?
|